COVID-19: faster authorisation for vaccines adapted to variants | Nieuws | Europees Parlement

 

COVID-19: faster authorisation for vaccines adapted to variants 

Persbericht 
 
 

MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

You can watch the debate live here.

On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

Background

On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

 
  • Direct naar de inhoud van de pagina (druk op "Enter")
  • Direct naar de inhoud van de pagina (druk op "Enter")Direct naar de inhoud van de pagina (druk op "Enter")
  • Rechtstreeks naar talenmenu (druk op "Enter")
  • Rechtstreeks naar talenmenu (druk op "Enter")Rechtstreeks naar talenmenu (druk op "Enter")
  • Rechtstreeks naar zoekmenu (druk op "Enter")
  • Rechtstreeks naar zoekmenu (druk op "Enter")Rechtstreeks naar zoekmenu (druk op "Enter")
  • BG - български
  • BG - български BG - българскиBG - български
  • ES - español
  • ES - español ES - españolES - español
  • CS - čeština
  • CS - čeština CS - češtinaCS - čeština
  • DA - dansk
  • DA - dansk DA - danskDA - dansk
  • DE - Deutsch
  • DE - Deutsch DE - DeutschDE - Deutsch
  • ET - eesti keel
  • ET - eesti keel ET - eesti keelET - eesti keel
  • EL - ελληνικά
  • EL - ελληνικά EL - ελληνικάEL - ελληνικά
  • EN - English
  • EN - English EN - EnglishEN - English
  • FR - français
  • FR - français FR - françaisFR - français
  • GA - Gaeilge
  • GA - Gaeilge GA - GaeilgeGA - Gaeilge
  • HR - hrvatski
  • HR - hrvatski HR - hrvatskiHR - hrvatski
  • IT - italiano
  • IT - italiano IT - italianoIT - italiano
  • LV - latviešu valoda
  • LV - latviešu valoda LV - latviešu valodaLV - latviešu valoda
  • LT - lietuvių kalba
  • LT - lietuvių kalba LT - lietuvių kalbaLT - lietuvių kalba
  • HU - magyar
  • HU - magyar HU - magyarHU - magyar
  • MT - Malti
  • MT - Malti MT - MaltiMT - Malti
  • NL - Nederlands
  • NL - Nederlands NL - NederlandsNL - Nederlands
  • PL - polski
  • PL - polski PL - polskiPL - polski
  • PT - português
  • PT - português PT - portuguêsPT - português
  • RO - română
  • RO - română RO - românăRO - română
  • SK - slovenčina
  • SK - slovenčina SK - slovenčinaSK - slovenčina
  • SL - slovenščina
  • SL - slovenščina SL - slovenščinaSL - slovenščina
  • FI - suomi
  • FI - suomi FI - suomiFI - suomi
  • SV - svenska
  • SV - svenska SV - svenskaSV - svenska
  • Naar pagina gaan Nieuws
  • Naar pagina gaan Nieuws Naar pagina gaan Nieuws Naar pagina gaanNieuws
  • Naar pagina gaan Leden
  • Naar pagina gaan Leden Naar pagina gaan Leden Naar pagina gaanLeden
  • Naar pagina gaan Over het Parlement
  • Naar pagina gaan Over het Parlement Naar pagina gaan Over het Parlement Naar pagina gaanOver het Parlement
  • Naar pagina gaan Plenaire vergadering
  • Naar pagina gaan Plenaire vergadering Naar pagina gaan Plenaire vergadering Naar pagina gaanPlenaire vergadering
  • Naar pagina gaan Commissies
  • Naar pagina gaan Commissies Naar pagina gaan Commissies Naar pagina gaanCommissies
  • Naar pagina gaan Delegaties
  • Naar pagina gaan Delegaties Naar pagina gaan Delegaties Naar pagina gaanDelegaties
  • Andere websites Andere websites
  • Naar pagina gaan Multimedia Centre
  • Naar pagina gaan Multimedia Centre Naar pagina gaan Multimedia Centre Naar pagina gaanMultimedia Centre
  • Naar pagina gaan Webpagina van de Voorzitter
  • Naar pagina gaan Webpagina van de Voorzitter Naar pagina gaan Webpagina van de Voorzitter Naar pagina gaanWebpagina van de Voorzitter
  • Naar pagina gaan Secretariaat-generaal
  • Naar pagina gaan Secretariaat-generaal Naar pagina gaan Secretariaat-generaal Naar pagina gaanSecretariaat-generaal
  • Naar pagina gaan Think tank
  • Naar pagina gaan Think tank Naar pagina gaan Think tank Naar pagina gaanThink tank
  • Naar pagina gaan EP Newshub
  • Naar pagina gaan EP Newshub Naar pagina gaan EP Newshub Naar pagina gaanEP Newshub
  • Naar pagina gaan Tot uw dienst
  • Naar pagina gaan Tot uw dienst Naar pagina gaan Tot uw dienst Naar pagina gaanTot uw dienst
  • Naar pagina gaan Bezoeken
  • Naar pagina gaan Bezoeken Naar pagina gaan Bezoeken Naar pagina gaanBezoeken
  • Naar pagina gaan Legislative train
  • Naar pagina gaan Legislative train Naar pagina gaan Legislative train Naar pagina gaanLegislative train
  • Naar pagina gaan Contracten en subsidies
  • Naar pagina gaan Contracten en subsidies Naar pagina gaan Contracten en subsidies Naar pagina gaanContracten en subsidies
  • Naar pagina gaan Registreren
  • Naar pagina gaan Registreren Naar pagina gaan Registreren Naar pagina gaanRegistreren
    Nieuws Europees Parlement NieuwsNieuws Europees Parlement Europees Parlement Menu Menu
  • Nieuws
  • Nieuws Nieuws Nieuws
  • Naar pagina gaan Startpagina
  • Naar pagina gaan Startpagina Naar pagina gaan Startpagina Naar pagina gaanStartpagina
  • Naar pagina gaan Europese zaken
  • Naar pagina gaan Europese zaken Naar pagina gaan Europese zaken Naar pagina gaanEuropese zaken
  • Naar pagina gaan Wereld
  • Naar pagina gaan Wereld Naar pagina gaan Wereld Naar pagina gaanWereld
  • Naar pagina gaan Economie
  • Naar pagina gaan Economie Naar pagina gaan Economie Naar pagina gaanEconomie
  • Naar pagina gaan Maatschappij
  • Naar pagina gaan Maatschappij Naar pagina gaan Maatschappij Naar pagina gaanMaatschappij
  • Naar pagina gaan Veiligheid
  • Naar pagina gaan Veiligheid Naar pagina gaan Veiligheid Naar pagina gaanVeiligheid
  • Pers
  • Pers Pers Pers
  • Naar pagina gaan Startpagina
  • Naar pagina gaan Startpagina Naar pagina gaan Startpagina Naar pagina gaanStartpagina
  • Naar pagina gaan Accreditatie
  • Naar pagina gaan Accreditatie Naar pagina gaan Accreditatie Naar pagina gaanAccreditatie
  • Naar pagina gaan Contact
  • Naar pagina gaan Contact Naar pagina gaan Contact Naar pagina gaanContact
  • Agenda
  • Agenda Agenda Agenda
  • Naar pagina gaan Hoogtepunten
  • Naar pagina gaan Hoogtepunten Naar pagina gaan Hoogtepunten Naar pagina gaanHoogtepunten
  • Naar pagina gaan Wekelijkse agenda
  • Naar pagina gaan Wekelijkse agenda Naar pagina gaan Wekelijkse agenda Naar pagina gaanWekelijkse agenda
  • Naar pagina gaan Briefing
  • Naar pagina gaan Briefing Naar pagina gaan Briefing Naar pagina gaanBriefing
  • Veelgestelde vragen
  • Veelgestelde vragen Veelgestelde vragen Veelgestelde vragen
  • #EuropeanenTegenCovid19
  • #EuropeanenTegenCovid19 #EuropeanenTegenCovid19 #EuropeanenTegenCovid19Naar het zoekveld
    Zoekopdracht starten Europees Parlement
    Pers   > Huidige pagina: COVID-19: faster authorisation for vaccines adapted to variants  
    Pers   > Pers  Pers > Huidige pagina: COVID-19: faster authorisation for vaccines adapted to variants   Huidige pagina: COVID-19: faster authorisation for vaccines adapted to variants   Huidige pagina:COVID-19: faster authorisation for vaccines adapted to variants  Pers  Pers >
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     
     

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

     
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     
     
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    Persbericht 
     

    COVID-19: faster authorisation for vaccines adapted to variants 

    COVID-19: faster authorisation for vaccines adapted to variants 
    COVID-19: faster authorisation for vaccines adapted to variants 
    Persbericht 
     
    Persbericht 
    Persbericht  ENVI  ENVIENVI 
     
     
     

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

     
     

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

     
     
     

    Deel deze pagina: 

    Deel deze pagina: 
    Deel deze pagina: 
  • Facebook Facebook 
  • Twitter Twitter 
  • LinkedIn LinkedIn 
  • Whatsapp Whatsapp 

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    MEPs will discuss and greenlight a new procedure to facilitate and accelerate the EU-wide approval of vaccines adapted to COVID-19 variants.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    You can watch the debate live here.

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    On Thursday, Members of the Environment, Public Health and Food Safety (ENVI) Committee will hold an exchange of views on a Commission delegated act providing a simplified authorisation procedure for COVID-19 vaccines that have already received EU authorisation but which are being adapted to be effective against variants of the virus.

    When: Thursday 15 April 2021, 10:00-11:00 (indicative timing)

    When

    Where: European Parliament in Brussels, room József Antall 4Q2 and videoconference

    Where

    You can watch the debate live here.

    here

    On Friday morning, the ENVI committee will also vote on a recommendation to give an early greenlight to the proposal, declaring that it raises no objections to it, in order to accelerate its introduction.

    Background

    Background

    On 24 March, the Commission introduced a measure to accelerate the authorisation of adapted COVID-19 vaccines. Before entering into force, any delegated act is scrutinised by the European Parliament and Council. If they do not intend to raise any objections, MEPs may decide to shorten this scrutiny period with a vote at committee level, followed by the approval of the recommendation during the next plenary session (according to Rule 111 paragraph six of Parliament’s Rules of Procedure).

    introduced a measureRule 111

    On 15 March, MEPs debated with experts on the efficacy of vaccines against mutations of the COVID-19 virus.

    debated with experts

    Contact: 

    Contact: 
    Contact: 
  • Dana POPP 

    Dana POPP Dana POPP 
    Press Officer 
    Press Officer Press Officer 
    Contactgegevens: 
    Contactgegevens: 
  • Telefoonnummer: (+32) 2 28 46330 (BXL) 
  • Telefoonnummer: (+32) 2 28 46330 (BXL) Telefoonnummer: (+32) 2 28 46330 (BXL)Telefoonnummer: (BXL) 
  • Telefoonnummer: (+33) 3 881 74903 (STR) 
  • Telefoonnummer: (+33) 3 881 74903 (STR) Telefoonnummer: (+33) 3 881 74903 (STR)Telefoonnummer: (STR) 
  • Mobiel telefoonnummer: (+32) 470 95 17 07 
  • Mobiel telefoonnummer: (+32) 470 95 17 07 Mobiel telefoonnummer: (+32) 470 95 17 07Mobiel telefoonnummer:  
  • E-mail: dana.popp@europarl.europa.eu 
  • E-mail: dana.popp@europarl.europa.eu E-mail: dana.popp@europarl.europa.euE-mail:  
  • E-mail: envi-press@europarl.europa.eu 
  • E-mail: envi-press@europarl.europa.eu E-mail: envi-press@europarl.europa.euE-mail:  
  • Twitteraccount: @EP_Environment 
  • Twitteraccount: @EP_Environment Twitteraccount: @EP_EnvironmentTwitteraccount:  
     
     

    Further information 

    Further information 
    Further information 
  • MEPs share concerns about COVID-19 variants (15.03.2021)  MEPs share concerns about COVID-19 variants (15.03.2021) 
  • Coronavirus: new procedure to facilitate and speed up approval of adapted vaccines against COVID-19 variants (European Commission, 24.03.2021)  Coronavirus: new procedure to facilitate and speed up approval of adapted vaccines against COVID-19 variants (European Commission, 24.03.2021) 
  • HERA incubator - preparing Europe for the increased threat of variants (European Commission, 17.02.2021)  HERA incubator - preparing Europe for the increased threat of variants (European Commission, 17.02.2021) 
  • Reflection paper on regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2 (European Medicines Agency, 25.02.2021)   Reflection paper on regulatory requirements for vaccines intended to provide protection against variant strain(s) of SARS-CoV-2 (European Medicines Agency, 25.02.2021)  
  • Free photos, video and audio material related to EU vaccines strategy  Free photos, video and audio material related to EU vaccines strategy 
     
     
     
     
     

    Productinformatie 

    REF.:  20210408IPR01612 

    Productinformatie 

    Productinformatie 
    Productinformatie 
    Productinformatie 
    REF.:  20210408IPR01612 
    REF.:  20210408IPR01612 
    REF.: REF.:REF.: 20210408IPR01612 20210408IPR01612 

    Deel deze pagina: 

    Deel deze pagina: 
    Deel deze pagina: 
  • Facebook Facebook 
  • Twitter Twitter 
  • LinkedIn LinkedIn 
  • Whatsapp Whatsapp Aanmelden voor e-mailupdatesAanmelden voor e-mailupdatesPdf-versie Pdf-versie 

    Voettekst 

    Voettekst Nieuws  Bekijk het menu: nieuws  Bekijk het menu: nieuws 
    Het Parlement in uw land 
  • Brussels  
  • Brussels   Brussels 
  • Den Haag  
  • Den Haag   Den Haag Tools 
  • Wetgevingsobservatorium  
  • Wetgevingsobservatorium   Wetgevingsobservatorium 
  • Multimedia Centre  
  • Multimedia Centre   Multimedia Centre 
  • EbS  
  • EbS   EbS 
    De Voorzitter van het Europees Parlement 
  • Webpagina van de Voorzitter van het Parlement  
  • Webpagina van de Voorzitter van het Parlement   Webpagina van de Voorzitter van het Parlement  Menu verbergen: Nieuws   Menu verbergen: Nieuws Europees Parlement  Menu bekijken: Europees Parlement   Menu bekijken: Europees Parlement 
  • Nieuws 
  • Nieuws  Nieuws 
  • Leden 
  • Leden  Leden 
  • Over het Parlement 
  • Over het Parlement  Over het Parlement 
  • Plenaire vergadering 
  • Plenaire vergadering  Plenaire vergadering 
  • Commissies 
  • Commissies  Commissies 
  • Delegaties 
  • Delegaties  Delegaties Menu verbergen: Europees Parlement Menu verbergen: Europees Parlement  

    Het Parlement in de sociale media  

    Het Parlement in de sociale media 
  • Facebook  
  • Facebook   Facebook 
  • Twitter  
  • Twitter   Twitter 
  • Facebook  
  • Facebook   Facebook 
  • LinkedIn  
  • LinkedIn   LinkedIn 
  • YouTube  
  • YouTube   YouTube 
  • Instagram  
  • Instagram   Instagram 
  • Pinterest  
  • Pinterest   Pinterest 
  • Snapchat  
  • Snapchat   Snapchat 
  • Reddit  
  • Reddit   Reddit Informatieve links 
  • Contact 
  • Contact Contact 
  • RSS 
  • RSS RSS 
  • Sitemap 
  • Sitemap Sitemap 
  • Juridische mededeling 
  • Juridische mededeling Juridische mededeling 
  • Privacybeleid 
  • Privacybeleid Privacybeleid 
  • Toegankelijkheid 
  • Toegankelijkheid Toegankelijkheid